Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) announced a profit for its first quarter that Increased, from last year
The company's bottom line totaled RMB95.17 million, or RMB0.1681 per share. This compares with RMB75.67 million, or RMB0.1425 per share, last year.
The company's revenue for the period rose 0.6% to RMB405.25 million from RMB403.01 million last year.
Tibet Cheezheng Tibetan Medicine Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB95.17 Mln. vs. RMB75.67 Mln. last year.-EPS: RMB0.1681 vs. RMB0.1425 last year.-Revenue: RMB405.25 Mln vs. RMB403.01 Mln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.